AMPH vs EFX · P/E 12, rev $732.0M vs P/E 54, rev $5.68B
Amphastar P (AMPH) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the AMPH and EFX stock pages for the full models.
Not investment advice.